会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof
    • 编码哺乳动物神经肽FF(NPFF)受体的DNA及其用途
    • US06709831B1
    • 2004-03-23
    • US09405558
    • 1999-09-24
    • Christophe P. G. GeraldKenneth A. JonesJames A. BoniniBeth E. BorowskyDouglas A. Craig
    • Christophe P. G. GeraldKenneth A. JonesJames A. BoniniBeth E. BorowskyDouglas A. Craig
    • G01N33566
    • C07K14/70571A01K2217/075
    • This invention provides isolated nucleic acids encoding mammalian NPFF receptors, purified mammalian NPFF receptors, vectors comprising nucleic acid encoding mammalian NPFF receptors, cells comprising such vectors, antibodies directed to mammalian NPFF receptors, nucleic acid probes useful for detecting nucleic acid encoding mammalian NPFF receptors, antisense oligonucleotides complementary to unique sequences of nucleic acid encoding mammalian NPFF receptors, transgenic, nonhuman animals which express DNA encoding normal or mutant mammalian NPFF receptors, methods of isolating mammalian NPFF receptors, methods of treating an abnormality that is linked to the activity of the mammalian NPFF receptors, as well as methods of determining binding of compounds to mammalian NPFF receptors, methods of identifying agonists and antagonists of NPFF receptors, and agonists and antagonists so identified.
    • 本发明提供编码哺乳动物NPFF受体的分离的核酸,纯化的哺乳动物NPFF受体,包含编码哺乳动物NPFF受体的核酸的载体,包含该载体的细胞,针对哺乳动物NPFF受体的抗体,用于检测编码哺乳动物NPFF受体的核酸的核酸探针, 与编码哺乳动物NPFF受体的核酸的独特序列互补的反义寡核苷酸,其表达编码正常或突变型哺乳动物NPFF受体的DNA的转基因非人动物,分离哺乳动物NPFF受体的方法,治疗与哺乳动物活性相关的异常的方法 NPFF受体,以及确定化合物与哺乳动物NPFF受体的结合的方法,识别NPFF受体的激动剂和拮抗剂的方法,以及如此鉴定的激动剂和拮抗剂。
    • 3. 发明授权
    • Peptide binding the KLVFF-sequence of amyloid-&bgr;
    • 肽结合淀粉样蛋白-β的KLVFF序列
    • US06331440B1
    • 2001-12-18
    • US09095106
    • 1998-06-10
    • Christer NordstedtJan NäslundJohan ThybergLars O. TjernbergLars Terenius
    • Christer NordstedtJan NäslundJohan ThybergLars O. TjernbergLars Terenius
    • G01N33566
    • C07K5/0821A61K38/00C07K5/0808C07K5/0815C07K5/0819C07K5/101C07K5/1019C07K5/1021C07K5/1024C07K14/4711G01N33/6896G01N2800/2821
    • The invention relates to compounds of formula (I) or (II), which are of interest especially for inhibition of polymerization of amyloid &bgr; peptide, as model substances for synthesis of amyloid &bgr; peptide-ligands, as tools for the identification of other organic compounds with similar functional properties and/or as ligands for detection of amyloid deposits using e.g., positron emission tomography (PET). Formula (II) is: R1—A′—Y′—Leu—X′—Z′—B′—R2 in which X′ means any group or amino acid imparting to the compound according to formula (I) the ability to bind to the KLVFF-sequence in amyloid &bgr; peptide, or two amino acids imparting the same ability, but with the proviso that one is not proline; Y′ means any amino acid; Z′ means any non-acidic amino acid; A′ means a direct bond or an &agr;-amino acid bonded at the carboxyl terminal of the &agr;-carboxy group or a di-, tri-, tetra- or pentapeptide bonded at the carboxyl terminal of the &agr;-carboxy group; B′ means a direct bond or an &agr;-amino acid bonded at the &agr;-nitrogen or a di-, tri-, tetra- or pentapeptide bonded at the &agr;-nitrogen of the N-terminal &agr;-amino acid; R1 is H or —CO—R3 bonded at the &agr;-amino group of A′; R2 is H, —OR4 or NR5R6, all bonded to the &agr;-carboxyl group of the &agr;-carboxyterminal of B′; R3 and R4 are straight or branched carbon chain of 1-4 carbon atoms; R5 and R6 are independently H, alkyl, cycloalkyl, aryl or substituted aryl or together are —(CH2)n— where n is 4-5; and R1 and R2 together can form a hydrocarbon ring of heterocyclic ring; all &agr;-amino acids being either D- or L-isomers.
    • 本发明涉及式(I)或(II)的化合物,其特别用于抑制淀粉样蛋白β肽的聚合作为淀粉样蛋白β肽配体的合成的模型物质,作为鉴定其它有机化合物的工具 具有类似的功能性质和/或用于使用例如正电子发射断层摄影(PET)检测淀粉样蛋白沉积物的配体。 式(II)是:R1-A'-Y'-Leu-X'-Z'-B'-R2,其中X'表示赋予根据式(I)的化合物的任何基团或氨基酸, 到淀粉样蛋白β肽中的KLVFF序列或赋予相同能力的两个氨基酸,但条件是一个不是脯氨酸; Y'表示任何氨基酸; Z'表示任何非酸性氨基酸; A'是指在α-羧基的羧基末端键合的直接键或α-氨基酸,或在α-羧基的羧基末端键合的二,三,四或五肽; B'是指在α-氮键合键或在N-末端α-氨基酸的α-氮键合的二 - ,三 - ,四 - 或五肽的直接键或α-氨基酸; R1是在A'的α-氨基键合的H或-CO-R3; R2是H,-OR4或NR5R6,均与B'的α-羧基末端的α-羧基键合; R3和R4是1-4个碳原子的直链或支链碳链; R 5和R 6独立地为H,烷基,环烷基,芳基或取代的芳基,或一起为 - (CH 2)n - ,其中n为4-5; R1和R2一起可以形成杂环的烃环; 所有α-氨基酸都是D-或L-异构体。